The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
620 jobs Number of planned job losses
Announcement Date
2 May 2003
Employment effect (start)
Foreseen end date
1 December 2003
Description
Due to the merger between Pfizer and Pharmacia, Pfizer announced a restructuring plan for its activities in France. The research and development unit of Fresnes, employing 285 persons, should be closed by the end of 2003. Morevoer, the unit of Guyancourt should also close by the end of 2003, affecting 335 workers over 450. The 115 other workers should be transfered to the headquarter of Paris.
Sources
2 May 2003: Les Echos
Citation
Eurofound (2003), Pfizer, Internal restructuring in France, factsheet number 59808, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/59808.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
